Is Real-World Evidence a Complement to Randomized Clinical Trials?
Use of real-world data has the potential to accelerate drug and device approvals in rare diseases and advance precision medicine initiatives.
Use of real-world data has the potential to accelerate drug and device approvals in rare diseases and advance precision medicine initiatives.
The use of AI in the diagnosis of skin cancer has real potential, yet current algorithms lack standardization and regulatory approval.
Evaluation of patient-reported outcomes (PROs) is an important component of measuring quality in cancer care.